Tuesday, December 4, 2012 Monday, December 3, 2012- Why This Healthcare Stock is Starting to Look Like Good Valueat Motley Fool (Mon, Dec 3)
- Pfizer Plans New Layoffs, GlaxoSmithKline Prepares for Pivotal Trial Results: Healthcare Business Recapat Wall St. Cheat Sheet (Mon, Dec 3)
- This Just In: Upgrades and Downgradesat Motley Fool (Mon, Dec 3)
- Amgen: Equity Report And Stock Valuationat Seeking Alpha (Mon, Dec 3)
- Renewed Hope for Alzheimer's Patients - and Investors?at Motley Fool (Mon, Dec 3)
- Daily Wrap: 12/3/2012at Forbes (Mon, Dec 3)
- Bristol-Myers Drops Alzheimer’s Drug on Little Benefitat Bloomberg (Mon, Dec 3)
- Dow Today: Pfizer (PFE) Higherat TheStreet (Mon, Dec 3)
- Pfizer laying off some US sales representativesAP (Mon, Dec 3)
- New Alzheimer's drug studies offer patients hopeAP (Mon, Dec 3)
- Merck Alzheimer's Drug Trial Challenges Lilly's Leadat Investor's Business Daily (Mon, Dec 3)
- Double Your Dividends In Big Pharmaat Seeking Alpha (Mon, Dec 3)
- Novartis Moving Forward In Genericsat Seeking Alpha (Mon, Dec 3)
- For Some Former SAC Capital Traders, Shorting Elan Was Dangerousat Forbes (Mon, Dec 3)
- Lpath Ranks Eighth Fastest Growing Biotechnology Company and 60th Overall Among N. America's Fastest Growing Companies in Deloitte's 2012 Technology Fast 500Marketwired (Mon, Dec 3)
- This Just In: Upgrades and Downgradesat Motley Fool (Mon, Dec 3)
- BioLine Is Approaching Its Moment Of Truthat Seeking Alpha (Mon, Dec 3)
- News Corp. Choose Robert Thomson as Publishing CEOat Bloomberg (Mon, Dec 3)
Sunday, December 2, 2012 Saturday, December 1, 2012Add PFE News to My Yahoo!   | |
|
0.13(0.45%) 11:38AM EDT - Nasdaq Real Time Price